Pathophysiology Of
Heart Disease
Overview Of Pathophysiology Of Heart Disease
With heart disease contributing to about 20 percent of deaths
in the United States each year, researchers have been doing
endless research to find out the risk factors and potential
heart disease vulnerabilities. The pathophysiology of heart
disease is making some discoveries that could mark some patients
as being weak.
It has been a well known fact that lipids play a major role
in coronary heart disease and the pathophysiology of heart
disease has revealed that a decrease in low-density lipoproteins
will lower the risk of heart disease.
It has been determined that the deposits of lipids on the
arterial wall is the main cause of heart disease and treatment
has focused on reducing the low-density lipoproteins to slow
or stop the development.
New pathophysiology of heart disease argues that coronary
heart disease could be a response to chronic inflammation
caused by injury or infections. The pathophysiology of heart
disease shows that low-density lipoprotein efforts can also
reduce the inflammation.
The study of heart disease and its causes, known as pathophysiology
of heart disease, is very much in the view of many medical
professionals. The Cleveland Clinic, located in Cleveland,
Ohio and Dr. Robert Chilton of the University of Texas Health
Science Center, are the leading researchers on the pathophysiology
of heart disease.
There are other studies which now suggesting that inflammations
can also be responsible for atherosclerosis, hardening of
the arteries, which is a form of coronary artery disease,
which will eventually lead to a heart attack.
Signs Of Vulnerable Patients
Ongoing pathophysiology of heart disease are starting to
mark patients with blood, which is weak to thickening, and
a high potential of to fatal arrhythmia, should be considered
as vulnerable to having a major coronary event in the near
future. Those with high levels of low-density lipoproteins
signs of arterial sclerosis and the threat of myocardial events
are at risk.
At the Cleveland Clinic continuing pathophysiology of heart
disease looks not only at the disease, but as well as preventing
and discovering new ways to hopefully reverse any coronary
activity that has been lost. Intervention therapy for heart
patients is a continuing study at the clinic.
However, until the pathophysiology of heart disease makes
a concrete finding of the variables that could be the culprits
of coronary heart disease, researchers recommend physicians
continue on the current path of reducing elevated levels of
low-density lipoproteins, commonly known as bad cholesterol,
either through lifestyle modification or medications.
| 
